$6.35
Today
as of Oct 2, 16:55 ET
Last 30 days
Recent Press Releases & News
Starling Oncology Leadership Highlights Recent and Upcoming Industry Conference Participation
Starling Oncology to Participate in Wells Fargo Healthcare Conference
Starling Oncology Launches Starling Nexus™, a Technology Platform Built to Optimize Oncology Provider Engagement and Accelerate High-Quality Care at Scale
STLN earnings at a glance
The options market is pricing a move of about ±55.1% after the report, a range of roughly $2.85 to $9.85 from today's $6.35. STLN beat the consensus EPS estimate in 0 of its last 2 reported quarters. Implied volatility is currently 353%. The share price of $6.35 sits near its 52-week high.
Overview
52-week range
$2.32
$7.13
84% of range
Avg surprise (last 2)
-11.9%
Avg reaction (last 0)
—
Latest IV / EM
353%
EM ±55.1% · $8 · Oct 16
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.08 | — | — | — | — | financials |
| Tue Mar 31, 2026 | Mar 2026 | $-0.02 | — | — | — | — | financials |
| Thu Nov 13, 2025 | Sep/2025 | $-0.14 | $-0.12 | -16.7% | — | — | earnings |
| Wed Aug 13, 2025 | Jun/2025 | $-0.15 | $-0.14 | -7.1% | — | — | earnings |
| Mon Mar 31, 2025 | Mar 2025 | $-0.21 | — | — | — | — | financials |
| Mon Sep 30, 2024 | Sep 2024 | $-0.18 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.17 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.22 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.19 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.19 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.33 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $161M | $147M | — | $137M | $120M | $104M | $100M | $99M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-5M | $-7M | — | $-8M | $-11M | $-10M | $-14M | $-16M |
| Net income | $-10M | $-2M | — | $-17M | $-17M | $-20M | $-16M | $-15M |
| EPS (diluted) | $-0.08 | $-0.02 | — | $-0.14 | $-0.15 | $-0.21 | $-0.18 | $-0.17 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | — | — | — | — | — | — | — | — |
| Inventory | $20M | $24M | $17M | $19M | $16M | $12M | $10M | $11M |
| Total current assets | $129M | $117M | $113M | $110M | $105M | $107M | $116M | $116M |
| Total assets | $178M | $168M | $165M | $164M | $160M | $164M | $179M | $180M |
| Long-term debt | $80M | $79M | $77M | $76M | $75M | $74M | $92M | $90M |
| Total liabilities | $203M | $185M | $180M | $176M | $169M | $159M | $164M | $150M |
| Total equity | $-25M | $-16M | $-16M | $-12M | $-9M | $5M | $15M | $29M |
Implied volatility — last 90 days
STLN earnings FAQ
What is STLN's expected move for earnings?
Options currently price a move of about ±55.1%, or $3.50 per share either way from $6.35.
What is STLN's implied volatility?
STLN's at-the-money implied volatility is about 353% based on the latest options snapshot.